Atossa Therapeutics, Inc. (ATOS) vs Impact Biomedical Inc. (IBO)
- Atossa Therapeutics, Inc. ATOS 2.91 +9.81%
- Impact Biomedical Inc. IBO 2.68 −15.19%
Atossa Therapeutics, Inc. and Impact Biomedical Inc. are both Biotechnology companies. Atossa Therapeutics, Inc. and Impact Biomedical Inc. are of similar size ($27.0M and $26.4M). Atossa Therapeutics, Inc. has negative trailing earnings, so its P/E is not meaningful; Impact Biomedical Inc. trades at 0.2×. Impact Biomedical Inc. has the higher net margin (2,254.3% vs 0.00%) and the higher return on invested capital (−22.8% vs −3,918.8%). Across the 15 metrics below, Impact Biomedical Inc. leads on 8 and Atossa Therapeutics, Inc. on 7.
Valuation
Profitability
| Metric | ATOS | IBO | Biotechnology median |
|---|---|---|---|
| Gross margin | 0.00% | (1,111.43%) | 65.16% |
| Operating margin | 0.00% | (14,600.00%) | 0.00% |
| Net margin | 0.00% | 2,254.29% | 0.00% |
| Free cash flow margin | 0.00% | (1,451.43%) | 0.00% |
| Return on equity | (89.23%) | 24.01% | (56.36%) |
| Return on assets | (77.91%) | 4.41% | (48.04%) |
| Return on invested capital | (3,918.83%) | (22.81%) | 0.00% |
Growth
Health
Dividend
Size
Any metric, up to five companies and an Excel export Powerpack